Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: anastrozole|DRUG: gefitinib
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC